全球细胞库外包市场规模、份额、成长分析（按类型、最终用户）- 产业预测，2024-2031 年

Global Cell Banking Outsourcing Market Size, Share, Growth Analysis, By Type(Master Cell Banking and Working Cell Banking), By End-User(Biopharmaceutical Companies and Contract Research Organizations (Cros).) - Industry Forecast 2024-2031

出版日期: 2024年03月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

在预测期内（2024-2031年），细胞库外包的全球市场规模预计为2022年的106亿美元，从2023年的123.4亿美元增长到2031年的415.8亿美元。预计复合年增长率为16.40 %。

在多种因素的推动下，全球细胞库外包市场将在未来几年显着成长。对单株抗体和高效生物治疗药物的需求不断增长，以及冷冻保存和细胞库製备的技术进步，推动了干细胞疗法日益普及的程度。根据 CellTrials.org 报导，2020 年第一季先进细胞疗法新临床试验的全球註册量激增近 30%，推动了对细胞银行服务的需求。此外，有利的政府措施以及细胞株保存和表征新技术的出现预计将进一步推动市场扩张。值得注意的是，市场上的主要企业正在进行合作研究以推动成长。这方面的一个例子是 Opsis Therapeutics、FUJIFILM Cellular Dynamics 和 Blue Rock Therapeutics 于 2021 年 5 月合作开发用于治疗眼科疾病的现成 iPSC。最近的研究表明，人类 iPS 细胞具有改善视力和血管健康的潜力，例如印第安纳大学医学院于 2022 年 3 月主导的一项研究，显示了改善与 2 型糖尿病相关的血管健康併发症的潜力。细胞库的管理此外，正在进行的旨在维持冷冻保存过程中组织稳定性的冷冻保护剂研究预计将推动市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

龙沙集团有限公司（瑞士）
SGS SA（瑞士）
查尔斯河实验室国际有限公司（美国）
药明康德（中国）
Eurofins Scientific（卢森堡）
默克公司（德国）
BioReliance 公司（美国）
Toxikon 公司（美国）
GlobalStem（美国）
Paragon Bioservices, Inc.（美国）
BSL Bioservice 科学实验室有限公司（德国）
ATCC（美国）
BioOutsource 有限公司（英国）
ViruSure 有限公司（奥地利）
赛多利斯股份公司（德国）
赛默飞世尔科技公司（美国）
科文斯公司（美国）
TATAA Biocenter AB（瑞典）
澳洲细胞银行
StemExpress, LLC（美国）

简介目录

Product Code: SQMIG35D2076

Global Cell Banking Outsourcing Market size was valued at USD 10.60 billion in 2022 and is poised to grow from USD 12.34 billion in 2023 to USD 41.58 billion by 2031, growing at a CAGR of 16.40% during the forecast period (2024-2031).

The global cell banking outsourcing market is poised for substantial growth in the forthcoming years, buoyed by various factors. A significant driver is the advancing techniques in cryopreservation and cell bank preparation, alongside the escalating adoption of stem cell therapies and mounting demand for monoclonal antibodies and efficient biopharmaceuticals. With global enrollments of new trials in advanced cell therapy surging by nearly 30% in the initial quarter of 2020, as reported by CellTrials.org, there's evident growing demand for cell banking services. Furthermore, favorable government initiatives and the advent of novel technologies for cell line storage and characterization are anticipated to further fuel market expansion. Notably, key market players are engaging in research collaborations to drive growth, exemplified by Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics joining forces in May 2021 to develop off-the-shelf iPSCs for ocular disease treatment. Recent studies, like the one led by the Indiana University School of Medicine in March 2022, showcasing the potential of human-induced pluripotent stem cells in improving visual acuity and vascular health, underscore the significance of stem cell banking in managing vascular health complications linked to type 2 diabetes. Moreover, ongoing research into cryoprotective agents aimed at preserving tissue stability during cryopreservation is expected to be another catalyst for market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segmental Analysis

Global Cell Banking Outsourcing market is segmented by type, end-user, and region. Based on type, the market can be segmented into master cell banking, and working cell banking. Based on end-user, the market is segmented into biopharmaceutical companies and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cell Banking Outsourcing Market

The escalating adoption of stem cell therapies stands as a significant catalyst propelling the global cell banking outsourcing market forward. Stem cell therapy, a swiftly advancing sector within regenerative medicine, holds promise in addressing various diseases and disorders. With the expanding demand for such therapies, there arises a pressing need for reliable and top-tier cell lines, thereby fueling the requirement for cell banking services. Consequently, this surge in demand is spurring the growth of the cell banking outsourcing market, as biopharmaceutical firms and CROs pursue streamlined and economical avenues for the production and preservation of these invaluable cell lines.

Restraints in the Global Cell Banking Outsourcing Market

One of the primary challenges facing the global cell banking outsourcing market is the substantial expense associated with cell banking services. The rigorous testing and characterization essential for guaranteeing the safety and quality of cell lines necessitate substantial investments in specialized equipment and infrastructure, consequently elevating service costs. Moreover, stringent regulations enforced by regulatory authorities pertaining to cell line production and storage further contribute to the overall expenses. These high costs might hinder the widespread adoption of such services, particularly in developing regions where healthcare budgets are constrained.

Market Trends of the Global Cell Banking Outsourcing Market

One notable trend in the cell banking outsourcing sector is the rising interest in personalized medicine, which seeks to deliver tailored treatments according to each patient's genetic composition. Achieving this goal involves utilizing cells customized to individual requirements. To meet this demand, cell banking outsourcing firms are directing investments towards technologies capable of producing genetically matched cells for patients. This trend is projected to fuel market expansion, reflecting the growing demand for personalized medical solutions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cell Banking Outsourcing Market by Type

Market Overview
Master Cell Banking and Working Cell Banking

Global Cell Banking Outsourcing Market by End-User

Market Overview
Biopharmaceutical Companies and Contract Research Organizations (Cros).

Global Cell Banking Outsourcing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReliance Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxikon Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlobalStem (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paragon Bioservices, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSL Bioservice Scientific Laboratories GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATCC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioOutsource Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViruSure GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TATAA Biocenter AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellBank Australia (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StemExpress, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments